The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease: The Pharmacists’ Perspective

American Journal of Lifestyle Medicine

Volumn 1, Issue 1, 2007, Pages 38-40

  Prevost, Rebecca R ^a  

^a Florida Hospital Celebration Health   (United Kingdom)

Author keywords

Healthy People 2010; medication counseling; pharmacists; screening

Indexed keywords

EID: 84877030538     PISSN: 15598276     EISSN: None     Source Type: Journal    
DOI: 10.1177/1559827606294595     Document Type: Review

References (6)

1. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006; 113; 2363-2372.
2. ACPE Accreditation Manual. Version 9.1. February 2004. Available at: www.acpeaccredt.org.
3. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000; 40: 157-165.
4. Best Practices for Hospital and Health-System Pharmacies: Position and Practice Standards of ASHP 2005-2006. Bethesda, Md: American Society of Health-System Pharmacists; 2005.
5. Centers for Disease Control and Prevention. Coverage for tobacco use cessation treatments. Available at: www.cdc.gov/tobacco/educational_materials/cessation/ReimbursementBrochureFull.pdf.
6. Calis KA, Hutchison LC, Elliott ME, et al. Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. ACCP White Paper. Pharmacotherapy. 2004; 24: 1241-1294.